<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04383431</url>
  </required_header>
  <id_info>
    <org_study_id>4-9/12/2018</org_study_id>
    <nct_id>NCT04383431</nct_id>
  </id_info>
  <brief_title>Cross-linking as Treatment in Infectious Keratitis</brief_title>
  <official_title>Standard Cross-linking Versus Accelerated Photoactivated Chromophore Cross-linking (PACK-CXL) for Treatment of Infectious Keratitis: A Comparative Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sohag University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sohag University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To compare between SCXL and ACXL for treatment of infectious keratitis
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Standard epithelium-off CXL, 30 minutes soaking time with riboflavin, 30 minutes UVA corneal
      irradiation continuous mode (Group A). Accelerated CXL 11 minutes soaking time with
      riboflavin, 8 minutes UVA corneal irradiation pulsed mode (Group B).
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 2, 2020</start_date>
  <completion_date type="Anticipated">February 2021</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Corneal healing</measure>
    <time_frame>3 months</time_frame>
    <description>Reepithelization of corneal ulcer which is measured in mm by slitlamp examination</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Corneal edema</measure>
    <time_frame>3 months</time_frame>
    <description>measurement of corneal edema by measurement of the corneal thickness in um by Optical Coherent Tomography</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Infectious Keratitis</condition>
  <arm_group>
    <arm_group_label>Standard CXL</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Standard epithelium-off CXL, 30 minutes soaking time with riboflavin, 30 minutes UVA corneal irradiation continuous mode.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Accelerated CXL</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Accelerated epithelium-off CXL, 12 minutes soaking time with riboflavin, 8 minutes UVA corneal irradiation continuous mode.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>PACK-CXL</intervention_name>
    <description>Standard epithelium-off CXL, 12 minutes soaking time with riboflavin, 8 minutes UVA corneal irradiation pulsed mode.</description>
    <arm_group_label>Accelerated CXL</arm_group_label>
    <arm_group_label>Standard CXL</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Fungal infectious keratitis

          -  bacterial infectious keratitis

          -  Must be not responding to medication

        Exclusion Criteria:

          -  Viral keratitis

          -  Pregnancy and lactation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mohammed Iqbal, MD. PhP</last_name>
    <role>Principal Investigator</role>
    <affiliation>00201068559840</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mohammed Iqbal, MD. PhP</last_name>
    <phone>00201068559840</phone>
    <email>dr_m_iqbal@yahoo.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Faculty of medicine</name>
      <address>
        <city>Sohag</city>
        <zip>82425</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mohammed Iqbal, MD. PhD</last_name>
      <phone>00201068559840</phone>
      <email>dr_m_iqbal@yahoo.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>April 27, 2020</study_first_submitted>
  <study_first_submitted_qc>May 7, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 12, 2020</study_first_posted>
  <last_update_submitted>June 2, 2020</last_update_submitted>
  <last_update_submitted_qc>June 2, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 4, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sohag University</investigator_affiliation>
    <investigator_full_name>Prof. Mohammed Iqbal</investigator_full_name>
    <investigator_title>Assistant Professor of Ophthalmology</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Infection</mesh_term>
    <mesh_term>Keratitis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Individual participant data will be allowed for sharing</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_time_frame>12 months after end of study</ipd_time_frame>
    <ipd_access_criteria>Ophthalmologists are allowed for access of data. they should email the principal investigator via dr_m_iqbal@yahoo.com to get the permission after reviewing the qualifications and quality of request</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

